apls stocktwits:Apellis Pharmaceuticals Inc (APLS) News
Apellis Pharmaceuticals Inc (APLS) News
FindApellisPharmaceuticalsInc(APLS)news,corporateevents,pressreleases,latestcompanyupdatesandheadlines.。其他文章還包含有:「APLSApellisPharmaceuticalsInc」、「ApellisPharmaceuticalsInc(APLS)Fundamental&...」、「Earnings」、「ApellisPharmaceuticals,Inc.(APLS)StockPrice」、「ApellisPharmaceuticals」、「ApellisPharmaceuticalsInc(APLS)StockForecast」、「APLS$APLSStockCharts,Analysis」、「APLSStoc...
查看更多 離開網站APLS Apellis Pharmaceuticals Inc
https://stocktwits.com
APLS Apellis Pharmaceuticals Inc. 3,077. $37.62. $1.60. (4.44%). Today. Watchers, 3,077. 52-Wk Low, $29.79. 52-Wk High, $73.80. Market Cap, $4.58B.
Apellis Pharmaceuticals Inc (APLS) Fundamental & ...
https://stocktwits.com
Get all financial information for Apellis Pharmaceuticals Inc (APLS) including Market ... Stocktwits. Sentiment · News · Earnings. Content. Upgrade. Trending.
Earnings
https://stocktwits.com
Checkout Apellis Pharmaceuticals Inc (APLS) earnings results, EPS expectations and actual EPS values for both quarterly and annual periods.
Apellis Pharmaceuticals, Inc. (APLS) Stock Price
https://finance.yahoo.com
Find the latest Apellis Pharmaceuticals, Inc. (APLS) stock quote, history, news and other vital information to help you with your stock trading and ...
Apellis Pharmaceuticals
https://finance.yahoo.com
Find the latest Apellis Pharmaceuticals, Inc. (APLS) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders ...
Apellis Pharmaceuticals Inc (APLS) Stock Forecast
https://www.tipranks.com
Based on 16 Wall Street analysts offering 12 month price targets for Apellis Pharmaceuticals in the last 3 months. The average price target is $71.40 with a ...
APLS $APLS Stock Charts, Analysis
https://www.stockconsultant.co
APLS, $APLS, Apellis Pharmaceuticals Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend ...
APLS Stock Soars 30% After Identifying Potential Culprit ...
https://www.investors.com
Shares of APLS stock rocketed Wednesday after Apellis identified the potential culprit behind inflammation following its drug, Syfovre.